Mark E. Sherman

22.4k total citations · 2 hit papers
159 papers, 12.5k citations indexed

About

Mark E. Sherman is a scholar working on Epidemiology, Oncology and Cancer Research. According to data from OpenAlex, Mark E. Sherman has authored 159 papers receiving a total of 12.5k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Epidemiology, 42 papers in Oncology and 35 papers in Cancer Research. Recurrent topics in Mark E. Sherman's work include Cervical Cancer and HPV Research (78 papers), Endometrial and Cervical Cancer Treatments (33 papers) and Genital Health and Disease (26 papers). Mark E. Sherman is often cited by papers focused on Cervical Cancer and HPV Research (78 papers), Endometrial and Cervical Cancer Treatments (33 papers) and Genital Health and Disease (26 papers). Mark E. Sherman collaborates with scholars based in United States, Poland and Costa Rica. Mark E. Sherman's co-authors include Mark Schiffman, Sholom Wacholder, Sophia Wang, Louise A. Brinton, Philip E. Castle, Rolando Herrero, Robert D. Burk, Montserrat García‐Closas, Allan Hildesheim and Susan S. Devesa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.

In The Last Decade

Mark E. Sherman

158 papers receiving 12.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice

2005 806 citations Philip E. Castle, Attila T. Lörincz et al. profile →
The 2001 Bethesda System: Terminology for Reporting Results of Cervical Cytology

2002 668 citations Diane Solomon, Mark E. Sherman et al. profile →

Peers

Countries citing papers authored by Mark E. Sherman

Since Specialization

Citations

This map shows the geographic impact of Mark E. Sherman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Sherman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Sherman more than expected).

Fields of papers citing papers by Mark E. Sherman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Sherman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Sherman. The network helps show where Mark E. Sherman may publish in the future.

Co-authorship network of co-authors of Mark E. Sherman

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Sherman. A scholar is included among the top collaborators of Mark E. Sherman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Sherman. Mark E. Sherman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer 2019 ·Modern Pathology ·Mustapha Abubakar, Jonine D. Figueroa, H. Raza Ali, Fiona M. Blows, Jolanta Lissowska, Carlos Caldas, Douglas F. Easton, Mark E. Sherman, Montserrat García‐Closas, Mitch Dowsett, Paul D.P. Pharoah	56
2	Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling 2015 ·Proceedings of the National Academy of Sciences ·Johan A. den Boon, Dohun Pyeon, Sophia Wang, Mark Horswill, Mark Schiffman, Mark E. Sherman, Rosemary E. Zuna, Zhishi Wang, Stephen M. Hewitt, (unknown), (unknown), Lisa Chung, Qiuling He, Paul F. Lambert, Joan L. Walker, Michael A. Newton, Nicolas Wentzensen, Paul Ahlquist	222
3	Metabolic Syndrome and Risk of Endometrial Cancer in the United States: A Study in the SEER–Medicare Linked Database 2015 ·Cancer Epidemiology Biomarkers & Prevention ·Britton Trabert, Nicolas Wentzensen, Ashley S. Felix, Hannah Yang, Mark E. Sherman, Louise A. Brinton	110
4	Benign Breast Tissue Composition in Breast Cancer Patients: Association with Risk Factors, Clinical Variables, and Gene Expression 2014 ·Cancer Epidemiology Biomarkers & Prevention ·Xuezheng Sun, Rupninder Sandhu, Jonine D. Figueroa, Gretchen L. Gierach, Mark E. Sherman, Melissa A. Troester	17
5	Tumor Intrinsic Subtype Is Reflected in Cancer-Adjacent Tissue 2014 ·Cancer Epidemiology Biomarkers & Prevention ·Patricia Casbas-Hernández, Xuezheng Sun, Erick Romàn-Pèrez, Monica D’Arcy, Rupninder Sandhu, Asahi Hishida, Kirk K. McNaughton, Xiaohong R. Yang, Liza Makowski, Mark E. Sherman, Jonine D. Figueroa, Melissa A. Troester	68
6	Relationship of Mammographic Density and Gene Expression: Analysis of Normal Breast Tissue Surrounding Breast Cancer 2013 ·Clinical Cancer Research ·Xuezheng Sun, Gretchen L. Gierach, Rupninder Sandhu, Tyisha Williams, Bentley R. Midkiff, Jolanta Lissowska, (unknown), Norman F. Boyd, Nicole B. Johnson, Jonine D. Figueroa, Mark E. Sherman, Melissa A. Troester	49
7	Incidence rates of endometrial hyperplasia, endometrial cancer and hysterectomy from 1980 to 2003 within a large prepaid health plan 2012 ·International Journal of Cancer ·James V. Lacey, Victoria M. Chia, Brenda B. Rush, (unknown), Douglas Richesson, Olga B. Ioffe, Brigitte M. Ronnett, Nilanjan Chatterjee, Bryan Langholz, Mark E. Sherman, Andrew G. Glass	31
8	Cytoplasmic Estrogen Receptor in Breast Cancer 2011 ·Clinical Cancer Research ·Allison W. Welsh, Donald R. Lannin, Gregory Young, Mark E. Sherman, Jonine D. Figueroa, N. Lynn Henry, Lisa Rydén, Chungyeul Kim, Richard R. Love, Rachel Schiff, David L. Rimm	49
9	A Long-term Prospective Study of Type-Specific Human Papillomavirus Infection and Risk of Cervical Neoplasia Among 20,000 Women in the Portland Kaiser Cohort Study 2011 ·Cancer Epidemiology Biomarkers & Prevention ·Mark Schiffman, Andrew G. Glass, Nicolas Wentzensen, Brenda B. Rush, Philip E. Castle, David R. Scott, Julie Buckland, Mark E. Sherman, (unknown), (unknown), Attila T. Lörincz, Sholom Wacholder, Robert D. Burk	106
10	Prevention of Persistent Human Papillomavirus Infection by an HPV16/18 Vaccine: A Community-Based Randomized Clinical Trial in Guanacaste, Costa Rica 2011 ·Cancer Discovery ·Rolando Herrero, Sholom Wacholder, Ana Cecilia Rodríguez, Diane Solomon, Paula González, Aimée R. Kreimer, Carolina Porras, John Schussler, Silvia Jiménez, Mark E. Sherman, Wim Quint, John T. Schiller, Douglas R. Lowy, Mark Schiffman, Allan Hildesheim	116
11	Effects of HIV-1 and Herpes Simplex Virus Type 2 Infection on Lymphocyte and Dendritic Cell Density in Adult Foreskins from Rakai, Uganda 2011 ·The Journal of Infectious Diseases ·Kristine Johnson, Andrew D. Redd, Thomas C. Quinn, Aleisha Collinson-Streng, Toby C. Cornish, Xiangrong Kong, Rajni Sharma, Aaron A.R. Tobian, (unknown), Mark E. Sherman, Godfrey Kigozi, David Serwadda, Maria J. Wawer, Ronald H. Gray	49
12	Assessment of Automated Image Analysis of Breast Cancer Tissue Microarrays for Epidemiologic Studies 2010 ·Cancer Epidemiology Biomarkers & Prevention ·Kelly L. Bolton, Montserrat García‐Closas, Ruth M. Pfeiffer, Máire A. Duggan, William Howat, Stephen M. Hewitt, Xiaohong R. Yang, Robert Cornelison, Sarah L. Anzick, Paul S. Meltzer, Sean Davis, Petra H. Lenz, Jonine D. Figueroa, Paul D.P. Pharoah, Mark E. Sherman	48
13	Determinants of seropositivity among HPV-16/18 DNA positive young women 2010 ·BMC Infectious Diseases ·(unknown), Carolina Porras, Christina N. Bennett, Mahboobeh Safaeian, (unknown), Ana Cecilia Rodríguez, Paula González, Martha L. Hutchinson, Silvia Jiménez, Mark E. Sherman, Sholom Wacholder, Diane Solomon, Leen‐Jan van Doorn, Catherine Bougelet, Wim Quint, Mark Schiffman, Rolando Herrero, Allan Hildesheim	27
14	DNA Hypermethylation of ESR1 and PGR in Breast Cancer: Pathologic and Epidemiologic Associations 2009 ·Cancer Epidemiology Biomarkers & Prevention ·Mia M. Gaudet, Mihaela Campan, Jonine D. Figueroa, Xiaohong R. Yang, Jolanta Lissowska, Beata Pepłońska, Louise A. Brinton, David L. Rimm, Peter W. Laird, Montserrat García‐Closas, Mark E. Sherman	56
15	Neither one‐time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancer 2009 ·International Journal of Cancer ·Philip E. Castle, Ana Cecilia Rodríguez, Robert D. Burk, Rolando Herrero, Allan Hildesheim, Diane Solomon, Mark E. Sherman, José Jerónimo, Mario Alfaro, Jorge Morales, Diego Guillén, Martha L. Hutchinson, Sholom Wacholder, Mark Schiffman	14
16	Genetic polymorphisms in the one‐carbon metabolism pathway and breast cancer risk: A population‐based case–control study and meta‐analyses 2007 ·International Journal of Cancer ·Jolanta Lissowska, Mia M. Gaudet, Louise A. Brinton, Stephen J. Chanock, Beata Pepłońska, Robert Welch, Witold Zatoński, Neonila Szeszenia‐Dąbrowska, Sue Park, Mark E. Sherman, Montserrat García‐Closas	100
17	A Prospective Study of Age Trends in Cervical Human Papillomavirus Acquisition and Persistence in Guanacaste, Costa Rica 2005 ·The Journal of Infectious Diseases ·Philip E. Castle, Mark Schiffman, Rolando Herrero, Allan Hildesheim, Ana Cecilia Rodríguez, M. Concepción Bratti, Mark E. Sherman, Sholom Wacholder, Robert E. Tarone, Robert D. Burk	303
18	Histopathologic extent of cervical intraepithelial neoplasia 3 lesions in the atypical squamous cells of undetermined significance low-grade squamous intraepithelial lesion triage study: implications for subject safety and lead-time bias. 2003 ·PubMed ·Mark E. Sherman, Sophia Wang, Robert E. Tarone, Laurie J. Rich, Mark Schiffman	81
19	Histopathologic Features of Ovaries at Increased Risk for Carcinoma 1999 ·International Journal of Gynecological Pathology ·Mark E. Sherman, Jennifer Lee, R. Tucker Burks, Jeffery P. Struewing, Robert J. Kurman, Patricia Hartge	39
20	Significant reduction in the rate of false-negative cervical smears with neural network-based technology (PAPNET testing system) 1997 ·Human Pathology ·Leopold G. Koss, Mark E. Sherman, Michael B. Cohen, (unknown), Teresa M. Darragh, Luciano B. Lemos, (unknown), Dorothy L. Rosenthal, Sedigheh Keyhani‐Rofagha, Klaus Schréiber, Philip T. Valente	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact